Dr Reddys Laboratories (RDY) Operating Margin Growth (1y) (2013 - 2026)

Dr Reddys Laboratories (RDY) Operating Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 304.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -157.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -650.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -2,102.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1,962.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 152.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -12,673.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -2,276.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -583.00
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn -1,924.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,924.00
Dec 31, 2025 -608.00
Jun 30, 2025 -291.00
Mar 31, 2025 -37.00
Dec 31, 2024 -154.00
Sep 30, 2024 -407.00
Jun 30, 2024 -260.00
Mar 31, 2024 -502.00
Dec 31, 2023 425.00
Sep 30, 2023 39.00
Jun 30, 2023 38.00
Mar 31, 2023 274.00
Dec 31, 2022 1,693.00
Sep 30, 2022 817.00
Jun 30, 2022 461.00
Mar 31, 2022 998.00
Dec 31, 2021 -919.00
Sep 30, 2021 1,295.00
Jun 30, 2021 399.00
Mar 31, 2021 -488.00